Gain Therapeutics, Inc. (GANX)
NASDAQ: GANX · IEX Real-Time Price · USD
1.190
-0.020 (-1.65%)
Jul 22, 2024, 9:54 AM EDT - Market open
Gain Therapeutics Employees
As of December 31, 2023, Gain Therapeutics had 32 total employees, including 29 full-time and 3 part-time employees. The number of employees increased by 1 or 3.23% compared to the previous year.
Employees
32
Change (1Y)
1
Growth (1Y)
3.23%
Revenue / Employee
n/a
Profits / Employee
-$660,762
Market Cap
22.31M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 32 | 1 | 3.23% |
Dec 31, 2022 | 31 | 2 | 6.90% |
Dec 31, 2021 | 29 | 15 | 107.14% |
Dec 31, 2020 | 14 | 10 | 250.00% |
Dec 31, 2019 | 4 | - | - |
Related Stocks
Company Name | Employees |
---|---|
ImmunoPrecise Antibodies | 102 |
Ekso Bionics Holdings | 72 |
Inspira Technologies Oxy B.H.N. | 42 |
Viracta Therapeutics | 40 |
Nephros | 31 |
OneMedNet | 20 |
Minerva Neurosciences | 9 |
Aprea Therapeutics | 7 |
GANX News
- 13 days ago - Gain Therapeutics Announces the Completion of Dosing in the Multiple Ascending Dose (MAD) of the Phase 1 Study of GT-02287, a Novel Small Molecule Therapy for Parkinson's Disease - GlobeNewsWire
- 23 days ago - Gain Therapeutics to Hold a Business Update Conference Call on July 1, 2024 - GlobeNewsWire
- 24 days ago - Gain Therapeutics, Inc. Appoints Gene Mack as Interim CEO - GlobeNewsWire
- 25 days ago - Gain Therapeutics Presents GT-02287 Data at Federation of European Neuroscience Societies (FENS) Forum 2024 Demonstrating Improvements in Cognitive Performance in a Preclinical Model of GBA1 Parkinson's disease - GlobeNewsWire
- 27 days ago - Gain Therapeutics to Participate at H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference - GlobeNewsWire
- 5 weeks ago - Gain Therapeutics Announces Pricing of $11.0 Million Public Offering - GlobeNewsWire
- 5 weeks ago - Gain Therapeutics Announces Proposed Public Offering - GlobeNewsWire
- 7 weeks ago - Gain Therapeutics Announces Acceptance of Late-Breaking Abstract for Poster Presentation at Federation of European Neuroscience Societies (FENS) Forum 2024 - GlobeNewsWire